The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC).
Hans J. Hammers
Research Funding - Bristol-Myers Squibb
Elizabeth R. Plimack
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck
Jeffrey R. Infante
No relevant relationships to disclose
Marc S. Ernstoff
Research Funding - Bristol-Myers Squibb
Brian I. Rini
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck; Pfizer
Research Funding - Acceleron Pharma; Bristol-Myers Squibb; GlaxoSmithKline; immatics; Merck; Millennium; Pfizer
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb; Genentech; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Prometheus
Albiruni R. A. Razak
No relevant relationships to disclose
Sumanta Kumar Pal
No relevant relationships to disclose
Martin Henner Voss
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Padmanee Sharma
Consultant or Advisory Role - Bristol-Myers Squibb; Dendreon; Jounce Therapeutics; MedImmune
Stock Ownership - Jounce Therapeutics
Research Funding - Bristol-Myers Squibb
Christian K. Kollmannsberger
No relevant relationships to disclose
Daniel Yick Chin Heng
Consultant or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Jennifer L. Spratlin
No relevant relationships to disclose
Yun Shen
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (B)
John F. Kurland
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Paul Gagnier
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Asim Amin
Consultant or Advisory Role - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb (I)
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb